Medirom Healthcare Technologies Free Cash Flow (FCF) History (MRM)

Medirom Healthcare Technologies reported −¥1.40B in free cash flow for fiscal 2024, a decrease of ¥635.5M from the previous fiscal year, with a free cash flow margin of −16.91%.

View full Medirom Healthcare Technologies company overview

Medirom Healthcare Technologies free cash flow by year

Medirom Healthcare Technologies annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20242024-12-31−¥1.40B−¥635.5M−16.91%
20232023-12-31−¥767.6M¥38.9M−11.24%
20222022-12-31−¥806.4M−¥153.6M−11.60%
20212021-12-31−¥652.9M−¥212.9M−12.07%
20202020-12-31−¥440.0M−¥440.4M−13.17%
20192019-12-31¥464,000+0.01%

Medirom Healthcare Technologies free cash flow growth trends

Over the last five reported fiscal years, free cash flow declined from ¥464,000 to −¥1.40B, a net decrease of ¥1.40B.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Medirom Healthcare Technologies filings at SEC.gov ↗